Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 11996
Country/Region: Botswana
Year: 2010
Main Partner: Not Available
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0

Funding will be requested to continue the support previously provided by TB CAP through a TBD organization that will operate in Botswana in partnership with the USG agencies and the PEPFAR-supported implementing partners, the World Health Organization (WHO) and the African Comprehensive HIV/AIDS Partnership (ACHAP). The TBD organization will support TB and TB/HIV work with technical assistance for capacity building and improved management of the laboratory and the Botswana National TB Program (BNTP).

Given the operational challenges faced by the BNTP, the TBD organization assistance will remain strategically important to provide support for the strengthening of the laboratory services for TB control, as well as the program management of patients dually infected with TB/HIV, with or without drug resistant tuberculosis. The TBD organization will continue to support, in partnership with the MOH, the development of the National TB Reference Laboratory (NTRL) into a well-functioning laboratory, fully equipped and capable of performing the roles and responsibilities needed for supporting excellent clinical management of drug susceptible and drug-resistant TB, routine drug resistance surveillance, and quality assurance of the sputum-smear microscopy network. The TDB organization will support three long-term advisors to the Ministry of Health at national level: one senior laboratory advisor, one laboratory External Quality Assurance advisor, and one TB/HIV advisor.

Personal annual work plans will be developed and in-service training conducted, as required. The TBD organization will provide regular support from a distance by e-mail and telephone consultations. Three country field visits per year will be conducted during the project period in support of staff and general technical activities, according to pre-agreed TORs with the MOH and USAID. Reporting on progress and activities will be quarterly. Annual performance evaluations with employees and beneficiaries will be conducted.

Funding for Care: TB/HIV (HVTB): $0

10.C.TB19: TBD follow-on TB CAP - Redacted

FY10 funds will be requested to support the salaries of one FSN and one contractor, and the travel costs of the FSN for site visits and attendance at regional and international meetings. Funds will also be requested to support the printing of the national TB/HIV guidelines and IEC materials, the maintenance and development of the electronic TB register (ETR.Net), the pilot project on mobile telephone technology for TB data transmission, and the procurement of one laptop and printer for use by TB/HIV program officers. Contingency funds will be requested for anticipated requests for emergency IC measures, e.g., ultraviolet light fittings, fans, and respirators in the MDR-TB sites and in selected Infectious Disease Care Clinics (IDCCs).

FY10 funds will be requested to provide TA from CDC Atlanta for the following activities: the assessment of treatment outcomes among TB patients with INH mono-resistance; a pilot project to intensify TB case finding in the health facilities in Francistown; an intervention project on TB infection control in the national prison network; and a project to assess the transmission of TB in outpatient care settings that serve persons with HIV-infection and evaluate measures to reduce TB transmission in these outpatient care settings.

Key Issues Identified in Mechanism
Tuberculosis